Santarus Inc. (SNTS) Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting
5/17/2013 7:24:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Santarus, Inc. (NASDAQ: SNTS) today announced that additional data from two pivotal clinical studies with UCERIS® (budesonide) extended release tablets will be featured in two poster presentations at the Digestive Disease Week® (DDW®) Meeting being held in Orlando, Fla. from May 18 – 21, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by